Logo image of ACON

ACLARION INC (ACON) Stock Fundamental Analysis

NASDAQ:ACON - Nasdaq - US6551874091 - Common Stock - Currency: USD

7.525  +0.26 (+3.51%)

After market: 7.31 -0.22 (-2.86%)

Fundamental Rating

3

Overall ACON gets a fundamental rating of 3 out of 10. We evaluated ACON against 36 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for ACON as it has an excellent financial health rating, but there are worries on the profitability. ACON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ACON had negative earnings in the past year.
In the past year ACON has reported a negative cash flow from operations.
ACON had negative earnings in each of the past 5 years.
In the past 5 years ACON always reported negative operating cash flow.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

The Return On Assets of ACON (-40.64%) is worse than 75.00% of its industry peers.
ACON has a Return On Equity of -42.44%. This is comparable to the rest of the industry: ACON outperforms 47.22% of its industry peers.
Industry RankSector Rank
ROA -40.64%
ROE -42.44%
ROIC N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

7

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACON has more shares outstanding
ACON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

Based on the Altman-Z score of -0.87, we must say that ACON is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACON (-0.87) is comparable to the rest of the industry.
ACON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.87
ROIC/WACCN/A
WACC9.68%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

ACON has a Current Ratio of 21.68. This indicates that ACON is financially healthy and has no problem in meeting its short term obligations.
ACON's Current ratio of 21.68 is amongst the best of the industry. ACON outperforms 100.00% of its industry peers.
A Quick Ratio of 21.68 indicates that ACON has no problem at all paying its short term obligations.
ACON has a better Quick ratio (21.68) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 21.68
Quick Ratio 21.68
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

ACON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.40%, which is quite impressive.
Looking at the last year, ACON shows a decrease in Revenue. The Revenue has decreased by -9.15% in the last year.
The Revenue has been decreasing by -8.83% on average over the past years.
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.77%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%89.9%

3.2 Future

Based on estimates for the next years, ACON will show a very strong growth in Earnings Per Share. The EPS will grow by 41.36% on average per year.
The Revenue is expected to grow by 121.56% on average over the next years. This is a very strong growth
EPS Next Y19.83%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year154.54%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -100K -200K -300K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1K -2K -3K

4.3 Compensation for Growth

A more expensive valuation may be justified as ACON's earnings are expected to grow with 41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACLARION INC

NASDAQ:ACON (6/30/2025, 8:00:00 PM)

After market: 7.31 -0.22 (-2.86%)

7.525

+0.26 (+3.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-15 2025-05-15/bmo
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-99.99%
Ins Owners0%
Ins Owner Change0%
Market Cap4.36M
Analysts82.86
Price Target11993.7 (159284.72%)
Short Float %2.41%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.58%
Min EPS beat(2)31.78%
Max EPS beat(2)99.37%
EPS beat(4)4
Avg EPS beat(4)41.81%
Min EPS beat(4)13.49%
Max EPS beat(4)99.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.16%
Min Revenue beat(2)-38.38%
Max Revenue beat(2)-37.94%
Revenue beat(4)0
Avg Revenue beat(4)-44.6%
Min Revenue beat(4)-56.98%
Max Revenue beat(4)-37.94%
Revenue beat(8)0
Avg Revenue beat(8)-57.06%
Revenue beat(12)2
Avg Revenue beat(12)-36.2%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2600%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4400%
EPS NY rev (1m)0%
EPS NY rev (3m)-4343.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 79.94
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.3
EV/EBITDA N/A
EPS(TTM)-3509.52
EYN/A
EPS(NY)-12.37
Fwd EYN/A
FCF(TTM)-10.14
FCFYN/A
OCF(TTM)-9.56
OCFYN/A
SpS0.09
BVpS27.21
TBVpS24.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.64%
ROE -42.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 165.6%
Cap/Sales 616.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.68
Quick Ratio 21.68
Altman-Z -0.87
F-Score4
WACC9.68%
ROIC/WACCN/A
Cap/Depr(3y)128.54%
Cap/Depr(5y)106.31%
Cap/Sales(3y)402.91%
Cap/Sales(5y)349.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.77%
EPS Next Y19.83%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%89.9%
Revenue Next Year154.54%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.79%
OCF growth 3YN/A
OCF growth 5YN/A